The same compound has also resulted in a reduction of pro-inflammatory cytokine level (IL-1β, IL-6, and IL-8) in ex-vivo organ cultures of mucosal explants from CD patients, thus demonstrating immunomodulatory activity in IBD [23]. Here, IL6 is linked to inflammatory bowel disease.